BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences Holdings, Inc. (BFNH) Revenue
Annual & quarterly revenue history · segment & region breakdown
BFNH · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBioForce Nanosciences Holdings, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2002 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | — |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | -$0.00B | -100.00% |
| 2019-12-31 | $0.00B | +$0.00B | +8.98% |
| 2018-12-31 | $0.00B | +$0.00B | +262.44% |
| 2017-12-31 | $0.00B | -$0.00B | -45.45% |
| 2016-12-31 | $0.00B | +$0.00B | +35.80% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income BioForce Nanosciences Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
BioForce Nanosciences Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from BioForce Nanosciences Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BFNH revenue · 4 questionsBFNH's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · BioForce Nanosciences Holdings, Inc. SEC filings · GAAP · BioForce Nanosciences Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026